ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 190 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,365 | -4.2% | 7,223 | +17.9% | 0.00% | 0.0% |
| Q2 2023 | $41,099 | -12.3% | 6,125 | +15.4% | 0.00% | 0.0% |
| Q1 2023 | $46,852 | -9.3% | 5,306 | -21.5% | 0.00% | 0.0% |
| Q4 2022 | $51,662 | +7.3% | 6,762 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $48,145 | -12.0% | 6,762 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $54,705 | -70.8% | 6,762 | +1.1% | 0.00% | -33.3% |
| Q4 2021 | $187,609 | -18.0% | 6,686 | -0.7% | 0.00% | 0.0% |
| Q3 2021 | $228,923 | -19.5% | 6,735 | -3.2% | 0.00% | -25.0% |
| Q2 2021 | $284,345 | +27.5% | 6,959 | +25.6% | 0.00% | +33.3% |
| Q1 2021 | $223,040 | -34.8% | 5,540 | -4.3% | 0.00% | -40.0% |
| Q4 2020 | $342,304 | +19.3% | 5,789 | -1.9% | 0.01% | 0.0% |
| Q3 2020 | $287,014 | +5.0% | 5,902 | +4.5% | 0.01% | 0.0% |
| Q2 2020 | $273,347 | +159.7% | 5,650 | +49.1% | 0.01% | +150.0% |
| Q1 2020 | $105,258 | +266.8% | 3,789 | +295.1% | 0.00% | – |
| Q4 2019 | $28,693 | -4.7% | 959 | -1.5% | 0.00% | -100.0% |
| Q3 2019 | $30,097 | – | 974 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
| Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
| Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
| Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
| TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
| Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
| Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
| Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
| Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |